A diarylsulphone non-nucleoside reverse transcriptase inhibitor with a unique sensitivity profile to drug-resistant virus isolates

Antiviral Chemistry and Chemotherapy

Volumn 7, Issue 5, 1996, Pages 243-252

  Buckheit Jr , R W ^a   Fliakas Boltz, V ^a   Russell, J D ^a   Snow, M ^a   Pallansch, L A ^a   Yang, S S ^b   Bader, J P ^b   Khan, T N ^c   Zanger, M ^c  

^a SOUTHERN RESEARCH INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF THE SCIENCES   (United States)

Author keywords

Combination anti HIV activity; Cross resistance; Diarylsulphones; Non nucleoside reverse transcriptase inhibitors

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; COSTATOLIDE; DIDANOSINE; DYE; KYNOSTATIN 272; LAMIVUDINE; NEVIRAPINE; NSC 602670; NSC 641530; NSC 665525; NSC 665526; NSC 667952; PROTEINASE INHIBITOR; RESOBENE; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; SULFONE DERIVATIVE; UC 10; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRUS ENZYME; ZALCITABINE; ZIDOVUDINE;

AMINO ACID SUBSTITUTION; ANTIVIRAL ACTIVITY; ARTICLE; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSS RESISTANCE; DRUG MECHANISM; DRUG POTENTIATION; DRUG RESISTANCE; DRUG SENSITIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LIPOPHILICITY; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; VIRUS ISOLATION; VIRUS MUTANT;

EID: 9544251506     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632029600700504     Document Type: Article

References (38)

1. Bader, J.P., McMahon, J.B., Schultz, R.J., Narayanan, V.L., Pierce, J.B., Harrison, W.A., Weislow, O.S., Midelfort, C.F., Stinson, S.F., and Boyd, M.R. (1991) Oxathiin carboxanilide, a potent inhibitor of human immunodeficiency virus reproduction. Proc Natl Acad Sci USA 88: 6740-6744.
2. Balzanni, J., Karlsson, A., Perez-Perez, M.J., Camarasa, M.J., and De Clercq, E. (1993a) Knocking-out concentrations of HIV-1 -specific inhibitors completely suppress HIV-1 infection and prevent the emergence of drug-resistant virus. Virology 196: 576-585.
3. Balzarini, J., Karlsson, A., Perez-Perez, M.J., Camarasa, M.J., Tarpley, W.G., and De Clercq, E. (1993b) Treatment of human immunodeficiency virus type 1 (HIV-1)-infected cells with combinations of HIV-1-specific inhibitors results in a different resistance pattern than does treatment with single-drug therapy. J Virol 67: 5353-5359.
4. Balzarini, J., Karlsson, A., Vandamme, A.M., Perez-Perez, M.J., Zhang, H., Vrang, L., Oberg, B., Backbro, K., Unge, T., and San-Felix, A. (1993c) Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2′,5′-bis-O-(tert-butyldimethylsilyl)-3′-spiro5″- (4″-amino-1″,2″-oxathiole-2″,2″-dioxide)]-beta-D- pentofuranosyl (TSAO) nucleoside analogues retain sensitivity to HIV-1-specific nonnucleoside inhibitors. Proc Natl Acad Sci USA 90: 6952-6956.
5. Boyer, P.L., Currens, M.J., McMabon, J.B., Boyd, M.R., and Hughes, S.H. (1993) Analysis of nonnucleoside drug-resistant variants of human immunodeficiency virus type 1 reverse transcriptase. J Virol 67: 2412-2420.
6. Buckheit Jr, R.W., Germany-Decker, J., Hollingshead, M.G., Allen, L.B., Shannon, W.M., Janssen, P.A., and Chirigos, M.A. (1993) Differential antiviral activity of two TIBO derivatives against the human immunodeficiency and murine leukemia viruses alone and in combination with other antiHIV agents. AIDS Res Hum Retroviruses 9: 1097-1106.
7. Buckheit Jr, R.W., Fliakas-Boltz, V.: Decker, W.D., Roberson, J.L., Pyle, C.A., White, E.L., Bowdon, B.J., McMahon, J.B., Boyd, M.R., Bader, J.P., Nickell, D.G., Barth, H., and Antonucci, T.K. (1994a) Biological and biochemical anti-HIV activity of the benzothiadiazine class of nonnucleoside reverse transcriptase inhibitors. Antiviral Res 25: 43-56.
8. Buckheit Jr, R.W., White, E.L., Germany-Decker, J., Allen, L.B., Ross, L.J., Shannon, W.M., Janssen, P.A.J., and Chirigos, M.A. (1994b) Cell based and biochemical analysis of the antiHIV activity of combinations of 3′-azido-3′-deoxythymidine and analogs of TIBO. Antiviral Chem Chemother5: 35-42.
9. Buckheit Jr, R.W., Fliakas-Boltz, V., Decker, W.D., Roberson, J.L., Stup, T.L., Pyle, C.A., White, E.L., McMahon, J.B., Currens, M.J., Boyd, M.R., and Bader, J.P. (1995a) Comparative anti-HIV evaluation of diverse HIV-1-specific reverse transcriptase inhibitor-resistant virus isolates demonstrates the existence of distinct phenotypic subgroups. Antiviral Res 26: 117-132.
10. Buckheit Jr, R.W., Kinjerski, T.L., Fliakas-Boltz, V., Russell, J.D., Stup, T.L., Pallansch, L.A., Brouwer, W.G., Dao, D.C., Harrison, W.A., Schultz, R.J., Bader, J.P., and Yang, S.S. (1995b) Structure-activity and cross-resistance evaluations of a series of human immunodeficiency virus type 1-specific compounds related to oxathiin carboxanilide. Antimicrob Agents Chemother 39: 2718-2727.
11. Bymes, V.W., Emim, E.A., Schleif, W.A., Condra, J.H., Schneider, C.L., Long, W.J., Wolfgang, J.A., Graham, D.J., Gotlib, L., and Schiabach, A.J. (1994) Susceptibilities of human immunodeficiency virus type 1 enzyme and viral vanants expressing multiple resistance-engendering amino acid substitutions to reserve transcriptase inhibitors. Antimicrob Agents Chemother 38: 1404-1407.
12. Cohen, K.A., Hopkins, J., Ingraham, R.H., Pargellis, C., Wu, J.C., Palladino, D.E., Kinkade, P., Warren, T.C., Rogers, S., and Adams, J. (1991) Characterization of the binding site for nevirapine (BI-RG-587), a nonnucleoside inhibitor of human immunodeficiency virus type-1 reverse transcriptase. J Biol Chem 266: 14670-14674.
13. Condra, J.H., Emini, E.A., Gotlib, L., Graham, D.J., Schiabach, A.J., Wolfgang, J.A., Colonno, R.J., and Sardana, V.V. (1992) identification of the human immunodeficiency virus reverse transcriptase residues that contribute to the activity of diverse nonnucleoside inhibitors. Antimicrob Agents Chemother 36: 1441-1446.
14. Dueweke, T.J., Pushkarskaya, T., Poppe, S.M., Swaney, S.M., Zhao, J.Q., Chen, I.S., Stevenson, M., and Tarpley, W.G. (1993) A mutation in reverse transcriptase of bis(heteroaryl)piperazine-resistant human immunodeficiency virus type 1 that confers increased sensitivity to other nonnucleoside inhibitors. Proc Natl Acad Sci USA 90: 4713-4717.
15. Gennaro, A.R., and Zanger, M. (1972) 1,2,3,4,-tetrahydroquinoline-8-sulphones. J Org Chem 9: 699-701.
16. Grob, P.M., Wu, J.C., Cohen, K.A., Ingraham, R.H., Shih, C.K., Hargrave, K.D., McTague, T.L., and Merluzzi, V.J. (1992) Nonnucleoside inhibitors of HIV-1 reverse transcriptase: nevirapine as a prototype drug. AIDS Res Hum Retroviruses 8: 145-152
17. Halberkahnn, J. (1921 a) Rearrangement and hydrolysis of toluene p-sulfonic acid and its n-methyl derivatives. Berichte der Deutschen Chemischen Gesellschaft 54: 1665-1675.
18. Halberkahnn, J. (1921b) Rearrangement and/or hydrolysis of tofuene p-sulfonic acid compounds of p-substituted anilines and their n-alkyl derivatives. Berichte der Deutschen Chemischen Gesellschaft 54: 1833-1849.
19. Halberkahnn, J. (1922) Rearrangement of toluene p-sulfonic acid; diphenyl, phenyl-p'tolyl, di-p-tolyl amides. Berichte der Deutschen Chemischen Gesellschaft 55: 3074-3095.
20. Jacobo-Molina, A., Ding, J., Nanni, R.G., Clark Jr, A.D., Lu, X., Tantillo, C., Williams, R.L., Kamer, G., Ferris, A.L., and Clark, P. (1993) Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA. Proc Natl Acad Sci USA 90: 6320-6324.
21. Kashman, Y., Gustafson, K.R., Fuller, R.W., Cardellina 2d, J.H., McMahon, J.B., Currens, M.J., Buckheit Jr, R.W., Hughes, S.H., Cragg, G.M., and Boyd, M.R. (1992) The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum [published erratum appears in J Med Chem 1993 Apr 16: 36 (8): 1110]. J Med Chem 35: 2735-2743.
22. Klunder, J.M., Hargrave, K.D., West, M., Cullen, E., Pal, K., Behnke, M.L., Kapadia, S.R., McNeil, D.W., Wu, J.C., and Chow, G.C. (1992) Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 2. Tricyclic pyridobenzoxazepinones and dibenzoxazepinones. J Med Chem 35: 1887-1897.
23. Maass, G., Immendoerfer, U., Koenig, B., Leser, U., Mueller, B., Goody, R., and Pfaff, E. (1993) Viral resistance to the thiazoio-iso-indolinones, a new class of nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother 37: 2612-2617.
24. McMahon, J.B., Gulakowski, R.J., Weislow, O.S., Schultz, R.J., Narayanan, V.L., Clanton, D.J., Pedemonte, R., Wassmundt, F.W., Buckheit Jr, R.W., and Decker, W.D. (1993) Diaryisulfones, a new chemical class of nonnucleoside antiviral inhibitors of human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother 37: 754-760.
25. McMahon, J.B., Buckheit Jr, R.W., Gulakowski, R.J., Currens, M.J., Vistica, D.T., Shoemaker, R.H., Stinson, S.F., Russell, J.D., Bader, J.P., Narayanan, V.L., Shultz, R.J., Brouwer, W.G., Felauer, E.E., and Boyd, M.R. (1995) Biological and biochemical anti-human immunodeficiency virus activity of UC-38, a new non-nucleoside reverse transcriptase inhibitor. J Pharmacol Exp Ther 276: 298-305.
26. Mellors, J.W., Larder, B.A., and Schinazi, R.F. (1995) Mutations in HIV-1 reverse transcriptase and protease associated with drug resistance. International Antiviral News 3: 8-13.
27. Merluzzi, V.J., Hargrave, K.D., Labadia, M., Grozinger, K., Skoog, M., Wu, J C., Shih, C.K., Eckner, K., Hattox, S., Adams, J., Roshthal, A.S., Faanes, R., Eckner, R.J., Koup, R.A., and Sullivan, J.L. (1990) Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor (published erratum appears in Science 1991 Jan 25: 251 (4992): 362]. Science 250: 1411-1413.
28. Nunberg, J.H., Schleif, W.A., Boots, E.J., O'Brien, J.A., Quintero, J.C., Hoffman, J.M., Emini, E.A., and Goldman, M.E. (1991) Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors. J Virol 65: 4887-4892.
29. Pauwels, R., Andries, K., Desmyter, J., Schols, D., Kukla, M.J., Breslin, H.J., Raeymaeckers, A., van Gelder, J., Woestenborghs, R., and Heykants, J. (1990) Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives. Nature 343: 470-4-74.
30. Prichard, M.N., and Shipman Jr, C. (1990) A three-dimensional model to analyze drug-drug interactions. Antiviral Res 14: 181-206.
31. Richman, D., Rosenthal, A.S., Skoog, M., Eckner, R.J., Chou, T.C., Sabo, J.P., and Merluzzi, V.J. (1991) BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine. Antimicrob Agents Chemother 35: 305-308.
32. Richman, D.D., Havlir, D., Corbeil, J., Looney, D., Ignacio, C., Spector, S.A., Sullivan, J., Cheeseman, S., Barringer, K., and Pauletti, D. (1994) Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy. J Virol 68: 1660-1666.
33. Saag, M.S., Emini, E.A., Laskin, O.L., Douglas, J., Lapidus, W.I., Schleif, W.A., Whitley, R.J., Hildebrand, C., Bymes, V.W., and Kappes, J.C. (1993) A short-term clinical evaluation of L-697661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. L-697661 Working Group. N Engl J Med 329: 1065-1072.
34. Smerdon, S.J., Jager, J., Wang, J., Kohlstaedt, L.A., Chirino, A.J., Friedman, J.M., Rice, P.A., and Steitz, T.A. (1994) Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 91: 3911-3915.
35. Wainberg, M.A., Drosopoulos, W.C., Salomon, B., Hsu, M., Borkow, G., Parniak, M.A., Zhengxian, G., Qingbin, S., Manne, J., Islam, S., Castriota, G., and Prasad, V.R. (1996) Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptase. Science 271: 1282-1285.
36. Witt, N.O., and Uermenyi, D. (1913) Studies of aryl-sulfamide. Berichte der Deutschen Chemischen Gesellschaft 46: 296-308.
37. Witt, N.O., and Truttwin, H. (1914) About the rearrangement of aryl-amides of m-nitrobenzenesulfonic acid. Berichte der Deutschen Chemischen Gesellschaft 47: 2786-2795.
38. Wu, J.C., Warren, T.C., Adams, J., Proudfoot, J., Skiles, J., Raghavan, P., Perry, C., Potocki, I., Fanna, P.R., and Grob, P.M. (1991) A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site. Biochemistry 30: 2022-2026.